Patent · US Active

1,2,4-triazine-6-carboxamide kinase inhibitors

US9040530B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

Portola Pharmaceuticals, Inc. · US

Inventors

Zhaozhong J. Jia · San Mateo, US
Brian Kane · Pleasant Hill, US
Jack W. Rose · San Mateo, US
Shawn M. Bauer · Pacifica, US
Yonghong Song · Foster City, US
Qing Xu · South San Francisco, US
Anjali Pandey · Fremont, US

Key dates

Filing date	Mar 15, 2013
Grant date	May 26, 2015
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are triazine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibiting Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.